Division of Internal Medicine, St. James's Hospital, Dublin, Ireland.
Nephrol Dial Transplant. 2011 Oct;26(10):3155-9. doi: 10.1093/ndt/gfr031. Epub 2011 Mar 15.
Both physiological- and laboratory-derived variables, alone or in combination, have been used to predict mortality among acute medical admissions. Using the Modification of Diet in Renal Disease (MDRD) not as an estimate of glomerular filtration rate but as an outcome predictor for hospital mortality, we examined the relationship between the MDRD value and in-hospital death during an emergency medical admission.
An analysis was performed on all emergency medical patients admitted between 1 January 2002 and 31 December 2008, using the hospital in-patient enquiry system, linked to the patient administration system and laboratory datasets. Hospital mortality (any in-patient death within 30 days) was obtained from a database of deaths occurring during the same period under physicians participating in the 'on-call' roster. Logistic regression was used to calculate unadjusted and adjusted odds ratios (OR) and 95% confidence intervals (CI) for MDRD value.
Univariate analysis identified those with MDRD value of <60 as possessing increased mortality risk. Their 30-day mortality rate was 21.63 versus 4.35% for patients without an abnormal value (P < 0.0001) with an OR of 6.07 (95% CI's 5.49, 6.73: P < 0.001). After adjustment for 12 other outcome predictors including comorbidity, the OR was 4.63 (4.08, 5.25: P < 0.0001). Using the Kidney Disease Outcomes Quality Initiative (KDOQI) class, the respective mortality rates by 30 days increased with a lower MDRD value, from 2.8% in KDOQI Class 1 to 48.6% in KDOQI Class 5. Outcome prediction of in-hospital death, at 5 and 30 days with the MDRD, yielded areas under the receiver operator curves of 0.84 (0.83, 0.84) and 0.77 (0.77, 0.78).
Many factors predict survival following an emergency medical admission. The MDRD value offers a novel readily available and reliable estimate of mortality risk.
生理和实验室衍生变量单独或联合使用已被用于预测急性内科住院患者的死亡率。本研究使用改良肾脏病膳食研究(MDRD)公式而非肾小球滤过率估算值作为医院死亡率的预测指标,旨在探讨 MDRD 值与内科急症住院患者住院期间死亡的关系。
本研究通过医院住院患者查询系统分析了 2002 年 1 月 1 日至 2008 年 12 月 31 日期间所有内科急症住院患者,该系统与患者管理系统和实验室数据集相关联。同期通过参与“值班”名单的医生获得的数据库获取院内死亡数据(30 天内任何住院死亡)。采用 logistic 回归计算 MDRD 值的未调整和调整比值比(OR)和 95%置信区间(CI)。
单因素分析发现 MDRD 值<60 的患者死亡风险增加。他们的 30 天死亡率为 21.63%,而 MDRD 值正常患者的死亡率为 4.35%(P<0.0001),OR 为 6.07(95%CI:5.49,6.73:P<0.001)。调整包括合并症在内的 12 个其他结局预测因素后,OR 为 4.63(4.08,5.25:P<0.0001)。根据肾脏病预后质量倡议(KDOQI)分级,30 天内死亡率随着 MDRD 值的降低而增加,从 KDOQI 分级 1 的 2.8%到 KDOQI 分级 5 的 48.6%。MDRD 预测住院 5 天和 30 天内的死亡,受试者工作特征曲线下面积分别为 0.84(0.83,0.84)和 0.77(0.77,0.78)。
许多因素预测内科急症住院患者的生存率。MDRD 值可提供一种新的、易于获得的可靠死亡率风险估计方法。